Loading EVA...

Exploring EVA...

Initializing EVA...

The first Generative Foundation Model for RNA design. Unifying the RNA world through advanced AI technology.

Quick Links

Home
Web Server
Team

Resources

Documentation
API Reference
GitHub Repository
Citation Guide

Connect

contact@eva.ai

Developed by researchers from

Xi'an Jiaotong University

Fudan University

Shanghai AI Laboratory

Back to Home

RNA Virus Design

Viral RNA

RNA virus genome analysis, attenuated vaccine design & antiviral target discovery.

Generate RNA sequence from scratch

Prompt Sequence (optional)

0 / 10,000A, U, G, C

Species (optional)

Max Length200

Research Highlights

Published examples and benchmark results for virus design.

Paper Examples

Attenuated SARS-CoV-2

Computationally designed attenuated coronavirus variant.

AUGCGAUUCGAACGUAACGCUUAGCGUAGCUAGCGAUUCGAACGUAACGCUUAGCGUAGCUAGCGAUUCGAACGUAACGCUUAGCGUAGCU

SARS-CoV-2Science 2024

Benchmark Results

Prediction

97%

Attenuation Accuracy

Accurate prediction of attenuating mutations.

View paper

Validated

Antiviral Targets

Novel antiviral target sites identified by the model.

View paper

Exploring EVA...

Back to Home

RNA Virus Design

Viral RNA

RNA virus genome analysis, attenuated vaccine design & antiviral target discovery.

Generate RNA sequence from scratch

Prompt Sequence (optional)

0 / 10,000A, U, G, C

Species (optional)

Max Length200

Research Highlights

Published examples and benchmark results for virus design.

Paper Examples

Attenuated SARS-CoV-2

Computationally designed attenuated coronavirus variant.

AUGCGAUUCGAACGUAACGCUUAGCGUAGCUAGCGAUUCGAACGUAACGCUUAGCGUAGCUAGCGAUUCGAACGUAACGCUUAGCGUAGCU

SARS-CoV-2Science 2024

Benchmark Results

Prediction

97%

Attenuation Accuracy

Accurate prediction of attenuating mutations.

View paper

Validated

Antiviral Targets

Novel antiviral target sites identified by the model.

View paper